Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
The method involves detailed molecular simulations of the receptor in its native membrane environment, with ensemble virtual screening focusing on its conformational mobility. When dealing with dimeric or oligomeric receptors, the whole functional complex is modelled, and the tentative binding pockets on and between the subunits are established to address all possible mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
P03372
UPID:
ESR1_HUMAN
Alternative names:
ER-alpha; Estradiol receptor; Nuclear receptor subfamily 3 group A member 1
Alternative UPACC:
P03372; Q13511; Q14276; Q5T5H7; Q6MZQ9; Q9NU51; Q9UDZ7; Q9UIS7
Background:
The Estrogen Receptor (ER-alpha), also known as Estradiol receptor or Nuclear receptor subfamily 3 group A member 1, plays a pivotal role in regulating gene expression and affecting cellular proliferation and differentiation. It functions through ligand-dependent nuclear transactivation, involving direct binding or association with other transcription factors, and mediates both genomic and non-genomic signaling pathways.
Therapeutic significance:
Estrogen resistance, a disorder characterized by resistance to estrogens despite elevated levels, implicates ER-alpha in its pathology. Understanding the role of ER-alpha could lead to novel therapeutic strategies for managing estrogen resistance and its associated metabolic complications.